BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29192064)

  • 1. Fyn-binding protein ADAP supports actin organization in podocytes.
    Wu Z; Blessing NA; Simske JS; Bruggeman LA
    Physiol Rep; 2017 Dec; 5(23):. PubMed ID: 29192064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TM4SF10 and ADAP interaction in podocytes: role in Fyn activity and nephrin phosphorylation.
    Azhibekov TA; Wu Z; Padiyar A; Bruggeman LA; Simske JS
    Am J Physiol Cell Physiol; 2011 Dec; 301(6):C1351-9. PubMed ID: 21881001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHROOM3-FYN Interaction Regulates Nephrin Phosphorylation and Affects Albuminuria in Allografts.
    Wei C; Banu K; Garzon F; Basgen JM; Philippe N; Yi Z; Liu R; Choudhuri J; Fribourg M; Liu T; Cumpelik A; Wong J; Khan M; Das B; Keung K; Salem F; Campbell KN; Kaufman L; Cravedi P; Zhang W; O'Connell PJ; He JC; Murphy B; Menon MC
    J Am Soc Nephrol; 2018 Nov; 29(11):2641-2657. PubMed ID: 30341149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pdlim2 is a novel actin-regulating protein of podocyte foot processes.
    Sistani L; Dunér F; Udumala S; Hultenby K; Uhlen M; Betsholtz C; Tryggvason K; Wernerson A; Patrakka J
    Kidney Int; 2011 Nov; 80(10):1045-54. PubMed ID: 21814175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nck proteins maintain the adult glomerular filtration barrier.
    Jones N; New LA; Fortino MA; Eremina V; Ruston J; Blasutig IM; Aoudjit L; Zou Y; Liu X; Yu GL; Takano T; Quaggin SE; Pawson T
    J Am Soc Nephrol; 2009 Jul; 20(7):1533-43. PubMed ID: 19443634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c‑Maf inducing protein inhibits cofilin‑1 activity and alters podocyte cytoskeleton organization.
    Yu L; Ye J; Liu Q; Feng J; Gu X; Sun Q; Lu G
    Mol Med Rep; 2017 Oct; 16(4):4955-4963. PubMed ID: 28791377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics.
    Meliambro K; Wong JS; Ray J; Calizo RC; Towne S; Cole B; El Salem F; Gordon RE; Kaufman L; He JC; Azeloglu EU; Campbell KN
    J Biol Chem; 2017 Dec; 292(51):21137-21148. PubMed ID: 28982981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actin dynamics at focal adhesions: a common endpoint and putative therapeutic target for proteinuric kidney diseases.
    Sever S; Schiffer M
    Kidney Int; 2018 Jun; 93(6):1298-1307. PubMed ID: 29678354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of TM4SF10, a Claudin/EMP/PMP22 family cell junction protein, during mouse kidney development and podocyte differentiation.
    Bruggeman LA; Martinka S; Simske JS
    Dev Dyn; 2007 Feb; 236(2):596-605. PubMed ID: 17195181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct regulation of nephrin tyrosine phosphorylation by Nck adaptor proteins.
    New LA; Keyvani Chahi A; Jones N
    J Biol Chem; 2013 Jan; 288(3):1500-10. PubMed ID: 23188823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of γ-adducin in actin cytoskeleton rearrangements in podocyte pathophysiology.
    Gao W; Liu Y; Fan L; Zheng B; Jefferson JR; Wang S; Zhang H; Fang X; Nguyen BV; Zhu T; Roman RJ; Fan F
    Am J Physiol Renal Physiol; 2021 Jan; 320(1):F97-F113. PubMed ID: 33308016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerulosclerosis Induced by Deficiency of Membrane-Associated Guanylate Kinase Inverted 2 in Kidney Podocytes.
    Shirata N; Ihara KI; Yamamoto-Nonaka K; Seki T; Makino SI; Oliva Trejo JA; Miyake T; Yamada H; Campbell KN; Nakagawa T; Mori K; Yanagita M; Mundel P; Nishimori K; Asanuma K
    J Am Soc Nephrol; 2017 Sep; 28(9):2654-2669. PubMed ID: 28539383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fyn Mediates High Glucose-Induced Actin Cytoskeleton Reorganization of Podocytes via Promoting ROCK Activation In Vitro.
    Lv Z; Hu M; Ren X; Fan M; Zhen J; Chen L; Lin J; Ding N; Wang Q; Wang R
    J Diabetes Res; 2016; 2016():5671803. PubMed ID: 26881253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IQGAP1 regulates actin cytoskeleton organization in podocytes through interaction with nephrin.
    Liu Y; Liang W; Yang Y; Pan Y; Yang Q; Chen X; Singhal PC; Ding G
    Cell Signal; 2015 Apr; 27(4):867-77. PubMed ID: 25652011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ischemic injury to kidney induces glomerular podocyte effacement and dissociation of slit diaphragm proteins Neph1 and ZO-1.
    Wagner MC; Rhodes G; Wang E; Pruthi V; Arif E; Saleem MA; Wean SE; Garg P; Verma R; Holzman LB; Gattone V; Molitoris BA; Nihalani D
    J Biol Chem; 2008 Dec; 283(51):35579-89. PubMed ID: 18922801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ARHGEF7 (
    Matsuda J; Maier M; Aoudjit L; Baldwin C; Takano T
    J Am Soc Nephrol; 2020 May; 31(5):996-1008. PubMed ID: 32188698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Planar cell polarity pathway regulates actin rearrangement, cell shape, motility, and nephrin distribution in podocytes.
    Babayeva S; Zilber Y; Torban E
    Am J Physiol Renal Physiol; 2011 Feb; 300(2):F549-60. PubMed ID: 20534871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrin mediates actin reorganization via phosphoinositide 3-kinase in podocytes.
    Zhu J; Sun N; Aoudjit L; Li H; Kawachi H; Lemay S; Takano T
    Kidney Int; 2008 Mar; 73(5):556-66. PubMed ID: 18033240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of dynamin, synaptojanin, and endophilin in podocyte foot processes.
    Soda K; Balkin DM; Ferguson SM; Paradise S; Milosevic I; Giovedi S; Volpicelli-Daley L; Tian X; Wu Y; Ma H; Son SH; Zheng R; Moeckel G; Cremona O; Holzman LB; De Camilli P; Ishibe S
    J Clin Invest; 2012 Dec; 122(12):4401-11. PubMed ID: 23187129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the Actin Cytoskeleton in Podocytes.
    Blaine J; Dylewski J
    Cells; 2020 Jul; 9(7):. PubMed ID: 32708597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.